Table 1.
DC | Key domains | SD | HB | Motif | var | Adhesion | SM | C/R Ab | P.reich. | Antibodies | Surface | Protection | References |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
DC11 | NTS-DBLα1·8/DBLζ | Rosetting/IgM | Yes | Rabbits | Yes | Opsonization | [1] | ||||||
DC16 | NTS-DBLα1·5/DBLζ | HB3VAR06 | Rosetting/IgM | Yes | Rabbits | Yes | Opsonization | [1, 2] | |||||
DC5 | Pf11_0008 | PECAM | No | Yes | Rat | Yes | Longitudinal | [3] | |||||
DC4 | CIDRα1·6/DBLβ3-D4 | var4 | ICAM1/EPCR | Yes | Yes | Yes | Rat/human | Yes | IE adhesion | [4–7] | |||
DC13 | CIDRα1·4 | EPCR | Yes | Yes | Human | Yes | [8–10] | ||||||
DC8 | CIDRα1·1 | IT4var19 | EPCR | Yes | Yes | Human | Yes | [8–11] | |||||
CIDRα1·1 | EPCR | Yes | Human | Yes | [6, 11] | ||||||||
CIDRα1·4 | EPCR | Yes | Human | Yes | [6, 11] | ||||||||
CIDRα1·5 | EPCR | Yes | Human | Yes | [6] | ||||||||
CIDRα1·8 | EPCR | Yes | Human | Yes | [6] | ||||||||
CIDRα2.8 | MC-var1 | CD36 | Yes | Aotus | No | Vaccination | [12] | ||||||
CIDRβ4 | Pf11_0008 | Yes | Human | Yes | Longitudinal | [13] | |||||||
NTS-DBLα1·6 | 1,2 | varO | Rosetting | No | Human/mice | Yes | [14, 15] | ||||||
NTS-DBLα1·8 | 3 | IT4var60 | Rosetting | Yes | Mouse | Yes | Anti-roset | [16] | |||||
NTS-DBLα1·8 | 1,2 | IT4var60 | Yes | Human | Anti-roset | [17] | |||||||
NTS-DBLα1·8 | 2–3 | ~2 | DYVPQ(F/Y)LR | Yes | Human | Anti-roset | [17] | ||||||
NTS-DBLα1·8 | 2 | 5 | RDSM(ALNRKE) | RD | Yes | Human/rat/rabbit | Yes | [18, 19] | |||||
1 | 4 | GACxPxRRxxLC | C32 cells | Yes | Aotus | Yes | Vaccination | [20] |
DC, domain cassette; SD, sub-domain; HB, homology block; var, commonly used model var; SM, association between expression and disease severity; C/R Ab, Whether cross-reactive antibodies have been detected; P. reich., identification of structure in Plasmodium reichenowi; antibodies, source of antibodies used; protection, the method used to demonstrate that antibodies are protective; longitudinal, longitudinal cohort studies of human populations; adhesion, reversal of infected erythrocyte adhesion; vaccination, protection demonstrated by vaccinating animals; anti-roset, rosette disruption by antibodies. RD, malaria with respiratory distress.
References: 1. Ghumra et al. (2012); 2. Stevenson et al. (2014); 3. Berger et al. (2013); 4. Jensen et al. (2004); 5. Bengtsson et al. (2013); 6. Lau et al. (2015); 7. Janes et al. (2011); 8. Avril et al. (2012); 9. Claessens et al. (2012); 10. Lavstsen et al. (2012); 11. Turner et al. (2013); 12. Gamain et al. (2001); 13. Magistrado et al. (2007); 14. Vigan-Womas et al. (2011); 15. Vigan-Womas et al. (2012); 16. Angeletti et al. (2012); 17. Albrecht et al. (2014); 18. Normark et al. (2007); 19. Blomqvist et al. (2013); 20. Patarroyo et al. (2014).